The Common Scientific Outline, or CSO, is a classification system organized around seven broad areas of scientific interest in cancer research:

  • Biology
  • Etiology (causes of cancer)
  • Prevention
  • Early detection, diagnosis, and prognosis
  • Treatment
  • Cancer control, survivorship, and outcomes research
  • Scientific model systems

The CSO is further subdivided into 38 subcategories. The CSO is laying a framework to improve coordination among research organizations, making it possible to compare and contrast the research portfolios of public, breast cancer nonprofit, and governmental research agencies within the US and UK

What cancer type classifications are used?

The ICR Partners work with a common list of cancer types to facilitate meaningful portfolio comparisons and collaboration between organizations.

How can I find more information on types of cancer?

There are a number of cancer information sources available to the public and health professionals on the web. Please consult the patient information sections of the ICR Partner’s websites for detailed information about cancer. As always, please consult a physician for professional guidance and information. 

Can I get funding information from the ICRP?

Information related to funding of individual research awards is not available on this site. Contact the individual CSO funding organization for information on its investment in cancer research. 

How are the three categories of research identified as project type on the ICRP defined?

Terminology for project types and the mechanisms used for describing research awards vary significantly among the cancer research organizations. To facilitate a common language for use on ICRP, three research categories have been identified to categorize the type of research listed.

  1. Research: includes basic, behavioral, translational and clinical research (including population & screening studies) and the infrastructure supporting these.
  2. Training: includes awards to support cancer research training, career development and educational opportunities for researchers.
  3. Clinical Trials: includes phase I, II and III trials.